Cenicriviroc for the treatment of COVID-19: first interim results of a randomised, placebo-controlled, investigator-initiated, double-blind phase II trial

Journal of global antimicrobial resistance

Florian Kurth, Elisa T Helbig, Lena J Lippert, …, Leif E Sander, Christoph Jochum, Frank Tacke

• DOI: 10.1016/j.jgar.2022.12.004
• PMID: 36572146
• PMCID: PMC9780636